| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |